GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Valuation Rank

Medrx Co (TSE:4586) Valuation Rank


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Medrx Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Medrx Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Medrx Co (TSE:4586) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Valuation Rank
Comparable Companies
TSE:4892 TSE:4883 TSE:4539 TSE:4597 TSE:4512 TSE:4524 TSE:4582 TSE:4574 TSE:4538 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Website
http://www.medrx.co.jp
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.